Bacterial Meningitis in Burkina Faso: Surveillance Using Field-Based Polymerase Chain Reaction Testing
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In addition to frequent epidemics of group A meningococcal disease, endemic bacterial meningitis due mostly to Neisseria meningitidis, pneumococcus, and Haemophilus influenzae type b is a serious problem in sub-Saharan Africa. The improved ability to identify the etiologic agent in cases of bacterial meningitis will facilitate more rapid administration of precise therapy. METHODS: To describe the epidemiology of bacterial meningitis and evaluate the usefulness of field-based polymerase chain reaction (PCR) testing, we implemented population-based meningitis surveillance in Burkina Faso during 2002-2003 by use of PCR, culture, and antigen detection tests. RESULTS: Among persons aged 1 month to 67 years, the incidences of meningococcal meningitis, pneumococcal meningitis, and Haemophilus influenzae type b meningitis were 19 cases (n=179), 17 cases (n=162), and 7.1 cases (n=68) per 100,000 persons per year, respectively. Of the cases of meningococcal meningitis, 72% were due to N. meningitidis serogroup W135. Pneumococcal meningitis caused 61% of deaths and occurred in a seasonal pattern that was similar to that of meningococcal meningitis. Of cases of pneumococcal meningitis and N. meningitidis serogroup W135 meningitis, 71% occurred among persons >2 years of age. Most patients, regardless of the etiology of their illness and the existence of an epidemic, received short-course therapy with oily chloramphenicol. Compared with culture as the gold standard, the sensitivity and specificity of PCR in the field were high; this result was confirmed in Burkina Faso and Paris. CONCLUSIONS: Precise and rapid identification of etiologic agents is critical for improvement in the treatment and prevention of meningitis, and, thus, PCR should be considered for wider use in Africa. Vaccines against Streptococcus pneumoniae, N. meningitidis (including serogroup W135), and H. influenzae type b all will have a major impact on the bacterial meningitis burden. Antibiotic recommendations need to consider the importance of S. pneumoniae, even during the epidemic season.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reported sensitivity of PCR for pneumococcal meningitis is high and reached 100% in the majority of conducted studies (median of 100%, range 79%–100%) (Table 1; see also Table S1 in the supplemental material) (49–58).”
From Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections (2024) · cites this paper as [58]
In the citing paper
“The sensitivity of bexA PCR ranged from 81% to 100% with a median of 93%, with a specificity ranging from 81% to 100% (median 94%) (54, 58, 65–68).”
From Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections (2024) · cites this paper as [58]
In the citing paper
“Other studies looking at single organism-specific PCR or multiplex assays for a variety of organisms, such as H. influenzae, S. pneumoniae, and N. meningitidis, have demonstrated increased sensitivity compared to conventional methods (28–30).”
From Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens (2016) · cites this paper as [30]
Citations
Cites
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
Bulletin of the World Health Organization
Frick, K. D., Lynch, M. C., West, S. K., Muñoz, B., & Mkocha, H. A. (2003) · Bulletin of the World Health Organization · Cited by 2,660
Corless, C. E., Guiver, M., Borrow, R., Edwards-Jones, V., Fox, A. J., & Kaczmarski, E. B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1553-1558.2001 · Cited by 607
Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of Serotypes
Frasch, C. E., Zollinger, W. D., & Poolman, J. T. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.4.504 · Cited by 460
Tunkel, A. R. (2001) · Cited by 308
Serogroup W135 meningococcal disease in Hajj pilgrims
Taha, M.-K., Achtman, M., Alonso, J.-M., Greenwood, B., Ramsay, M., Fox, A., Gray, S., & Kaczmarski, E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03502-9 · Cited by 267 · cited 1×
“meningitidis serogroup W135 meningitis has been recognized since 1982 [4], but outbreaks have been documented only recently [5-8].”
BackgroundSelf-citationTaha, M.-K. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.855-857.2000 · Cited by 260 · cited 2×
“PCR has a high sensitivity and specificity [12, 13, 15], and the lower limit of bacterial concentrations necessary for detection are such that false-positive results caused by transient contamination (e.”
BackgroundSelf-citationFailure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis
Friedland, I. R., Klugman, K. P., & Klugman, K. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90087-j · Cited by 191 · cited 1×
“Although few data exist with regard to efficacy, the use of chloramphenicol therapy for pneumococcal meningitis may lead to treatment failure [39], a situation that likely will worsen with the spread of chloramphenicol-resistant organisms [40, 41].”
BackgroundEpidemiology of bacterial meningitis in Niamey, Niger, 1981-96.
Campagne, G., Schuchat, A., Djibo, S., Ousseini, A., Cissé, L., & Chippaux, J. (1999) · Europe PMC (PubMed Central) · Cited by 182
Rådström, P., Bäckman, A., Qian, N., Kragsbjerg, P., Påhlson, C., & Olcén, P. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.11.2738-2744.1994 · Cited by 179 · cited 1×
“, nasopharyngeal carriage) are unlikely to occur [22-24].”
Background
Research works printed but not linked: 5
- Campagne, 1999, Bulletin of the World Health Organization, 77, 499
- 1982, Lancet, 11, 1335
- 2003, Emerging infectious diseases, 9, 486
- 2001, 19, 3420
- 2001, Bulletin de la Soci t de pathologie exotique (1990), 94, 300
Cited by
Items 101–161 of 161
Blumental, S., Moïsi, J. C., Roalfe, L., Zancolli, M., Johnson, M., Burbidge, P., Borrow, R., Yaro, S., Mueller, J. E., Gessner, B. D., et al. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00758-14 · Cited by 11
Self-citationThe epidemiology of Neisseria meningitidis meningitis in Togo during 2003–2005
Adjogble, K., Lourd, M., Njanpop‐Lafourcade, B., Traoré, Y., Hlomaschi, A. F. S., Amegatse, K. A., Agbenoko, K., Sanou, O., Kroman, S. S., Mueller, J. E., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.040 · Cited by 10
Self-citationMeningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
Tall, H., Yaro, S., Kpoda, H., Ouangraoua, S., Trotter, C. L., Njanpop‐Lafourcade, B., Findlow, H., Bai, X., Martin, C., Nwakamma, I. J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ519 · Cited by 10
“This 4-year period is longer than the previously observed period of MenA absence during 2002–2003 [13], which suggests that the”
ResultSelf-citationPneumococcal Polysaccharide Vaccines
Grabenstein, J. D., & Musher, D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00046-8 · Cited by 11
Development and Evaluation of a Dipstick Diagnostic Test for Neisseria meningitidis Serogroup X
Agnememel, A., Traincard, F., Dartevelle, S., Mulard, L. A., Mahamane, A. E., Oukem‐Boyer, O. O. M., Denizon, M., Kacou-N'douba, A., Dosso, M. B., Gaké, B., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02444-14 · Cited by 12
“not used as it has been constantly shown to be less sensitive than PCR (18).”
BackgroundMethodInfluentialSelf-citationSoeters, H. M., Kambiré, D., Sawadogo, G., Ouedraogo-Traoré, R., Bicaba, B. W., Médah, I., Sangaré, L., Ouédraogo, A., Ouangraoua, S., Yaméogo, I., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.002 · Cited by 12
Yaméogo, T. M., Kyelem, C. G., Poda, G. E. A., Sombié, I., Ouedraogo, M. S., & Millogo, A. (2010) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-010-0123-3 · Cited by 9
“La mise en évidence d’un diplocoque Gram négatif n’est pas en effet toujours synonyme de méningocoque A, les sérogroupes C, W135 et récemment X, circulant aussi dans le pays [4,14,24].”
BackgroundSelf-citationImproved detection of microbiological pathogens: role of partner and non-governmental organizations
Owusu, M., Nkrumah, B., Acheampong, G., Mensah, E. K., Komei, A. A.-K., Sroda, F. K., Sambian, D., Emery, S. L., Maryogo-Robinson, L., Asante, K., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05999-8 · Cited by 9
“This Global Health Security pathogen is the leading cause of bacterial meningitis, with an average mortality rate of 25%, despite effective antibiotic therapy and improved intensive care facilities [38].”
BackgroundMeningococcal carriage and immunity in western Burkina Faso, 2003
Yaro, S., Traoré, Y., Tarnagda, Z., Sangaré, L., Njanpop‐Lafourcade, B., Drabo, A., Findlow, H., Borrow, R., Nicolas, P., Gessner, B. D., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.039 · Cited by 9
Self-citationThe Epidemiology of Haemophilus influenzae Type b Meningitis in Burkina Faso
Yaro, S., Lourd, M., Naccro, B., Njanpop‐Lafourcade, B., Hien, A., Ouedraogo, M. S., Traoré, Y., Schouls, L. M., du Châtelet, I. P., & Gessner, B. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000217371.38080.8a · Cited by 9
“Haemophilus influenzae type b (Hib) meningitis is the predominant cause of childhood meningitis in most areas of the world and Africa has some of the highest reported incidences worldwide.(1,2) Although several countries in Eastern and Southern Africa have introduced Hib conjugate vaccine into routine infant immunizat…”
BackgroundSelf-citationCarnalla-Barajas, M. N., Soto‐Noguerón, A., Martínez‐Medina, L., Olvera-Herrera, M. E., Mosqueda-Gómez, J. L., Rodríguez-Cortez, P., Morfín‐Otero, R., Rodríguez-Noriega, E., Luévanos-Velázquez, A., Merlo-Palomera, M., et al. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00826-x · Cited by 8
“In African countries, the incidence rates are still substantially higher at 10–40 × 10,000 persons per year [4, 5].”
BackgroundMcHugh, M. P., Gray, S. J., Kaczmarski, E. B., & Guiver, M. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000154 · Cited by 10
“Nucleic-acid-based detection of N. meningitidis and S. pneumoniae has previously been shown to have high sensitivity and specificity (Bøving et al., 2009; Corless et al., 2001; Parent du Châtelet et al., 2005; Sacchi et al., 2011; Tzanakaki et al., 2005).”
BackgroundMobile laboratory to improve response to meningitis epidemics, Burkina Faso epidemic season 2004
Ouédraogo, R., Njanpop‐Lafourcade, B., Jaillard, P., Traoré, Y., Mueller, J. E., Aguilera, J.-F., Dabal, M., Tiendrebeogo, S. R. M., Göhde, W., da Silva, A., et al. (2008) · Field Actions Science Reports · doi:10.5194/facts-1-1-2008 · Cited by 8
Self-citationCoovadia, Y. M., Zimba, T. F., Nota, D. T., Langa, J. C., & Monteiro, L. (2009) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.614 · Cited by 8
“meningitidis causes bacterial meningitis in 80-95% of cases during epidemic periods and up to 50% in non-epidemic situations in the above mentioned African area [8,9,10].”
BackgroundKaboré, L., Galetto-Lacour, A., Sidibé, A. R. O., & Gervaix, A. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1917391 · Cited by 7
Ahmed, J., & Malik, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00033-1 · Cited by 8
Bacterial Paediatric Meningitis Laboratory Diagnosis
Robertson, G. M. M. (2015) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000204 · Cited by 6
“Both the increased detection rate and the wider range of pathogens detected using PCR in this and in other studies [13,21-23] suggest the importance of including PCR in the range of diagnostic tests available for the diagnosis of meningitis as a single test does not provide sufficient sensitivity, Latex agglutination…”
BackgroundOuangraoua, S., Schlumberger, M., Yaro, S., Ouédraogo, A., Sanou, S., Drabo, A. K., Yaméogo, T. M., & Ouédraogo, R. (2014) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-014-0329-2 · Cited by 6
“De plus, des moyens matériels ont été fournis pour que les LCR suspects à l’examen direct au niveau de ces laboratoires soient acheminés au niveau central, testés au latex (PastorexTM) [3], mis en culture, et soumis au test PCR [11].”
BackgroundAlonso, J., Bertherat, E., Perea, W., Borrow, R., Chanteau, S., Cohet, C., Dodet, B., Greenwood, B. M., LaForce, F. M., Rouzic, E. M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.037 · Cited by 6
Epidemiology, Diagnosis, and Treatment of Serious Pneumococcal Infections in Children
Madhi, S. A., & Pelton, S. I. (2014) · ASM Press eBooks · doi:10.1128/9781555815820.ch8 · Cited by 6
Streptococcus pneumoniae invasive infections in Burkina Faso, 2007 to 2011
Chaibou, Y., Sanou, I., Congo-Ouédraogo, M., Kienou, M., Ouattara, K., Somlaré, H., Traore, A. S., & Sangaré, L. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.01.014 · Cited by 4
Moïsi, J. C., Yaro, S., Kroman, S. S., Gouem, C., Bayane, D., Ganama, S., Meda, I. B., Nacro, B., Njanpop‐Lafourcade, B., Ouangraoua, S., et al. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy075 · Cited by 7
Self-citationMarcelo Reyes, S., Torres, J. P., Valeria Prado, J., & Roberto Vidal, A. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000300009 · Cited by 5
The Changing Landscape of Epidemic Bacterial Meningitis in Africa: New Opportunities for Prevention
Butler, J. C., & Levine, O. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/431154 · Cited by 4
“Leimkugel et al. reported that, in Ghana, the case-fatality rate for pneumococcal meningitis is 140% and is several-fold greater than the case-fatality rate for meningococcal meningitis [1], which is consistent with findings from other recent studies in Africa and Europe [6, 7, 9].”
ResultCarga de la meningitis bacteriana en Cuba, año 2000
Seuc, A. H., Pérez, A. E., Dickinson, F., Ortiz, D. V., & Domínguez, E. (2008) · Revista Cubana de Salud Pública · doi:10.1590/s0864-34662008000200005 · Cited by 4
World Health Organization (2025) · World Health Organization eBooks · doi:10.2471/b09348 · Cited by 4
A weak link to improving health outcomes in low-income countries : laboratories
Boillot, F. (2009) · Cited by 3
Soysal, A., Toprak, D., Türkoğlu, S., & Bakır, M. (2017) · BMC Microbiology · doi:10.1186/s12866-016-0834-0 · Cited by 3
“meningitidis serogroups A, X and W; and [3] the N.”
Thiongane, O., Graham, J., & Broutin, H. (2017) · Anthropologie & développement · doi:10.4000/anthropodev.607 · Cited by 3
Meningococcal Control in the United States and Africa
Plotkin, S. A., & Kaplan, S. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/500513 · Cited by 3
“digenous group of bacteria [13, 14].”
Mueller, J. E., Yaro, S., Ouédraogo, M. S., Levina, N., Njanpop‐Lafourcade, B., Tall, H., Idohou, R. S., Sanou, O., Kroman, S. S., Drabo, A., et al. (2013) · PLoS ONE · doi:10.1371/annotation/38175137-0da2-4268-a959-c9ac06da9b3e · Cited by 3
Self-citationPneumococcal Polysaccharide Vaccines
Grabenstein, J. D., & Musher, D. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00048-7 · Cited by 2
Travel-related Neisseria meningitidis Serogroup W135 Infection, France
Prifert, C., Streng, A., Krempl, C. D., Liese, J. G., & Weißbrich, B. (2013) · Cited by 2
Taha, M. (2012) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/s1166-8598(12)58119-6 · Cited by 3
Self-citationTsang, R. S. W., Deeks, S., Wong, K., Marchand‐Austin, A., & Jamieson, F. (2016) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v42i12a06f · Cited by 2
“Ce clone s’est ensuite propagé en Afrique subsaharienne (16) et en Amérique du Sud (17,18).”
New diagnostic tools for central nervous system infection
Ziai, W. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282ff5ba0 · Cited by 2
Impact of Changing Epidemiology on Vaccination Strategies in Africa
Taha, M., & Deghmane, A. (2010) · Future Microbiology · doi:10.2217/fmb.10.57 · Cited by 2
Self-citationNeisseria meningitis serogroup X outbreak in Burkina Faso, 2009-2010
Yaro, S., Drabo, A., Ouangraoua, S., Kirakoya‐Samadoulougou, F., Mueller, J. E., Sanou, O., Tall, H., Jaillard, P., Njanpop‐Lafourcade, B., Macq, J., et al. (2012) · Open Journal of Internal Medicine · doi:10.4236/ojim.2012.22010 · Cited by 1
“This serogroup emerged between 2000 and 2002 [8,30], then it remained limited to Burkina Faso, without epidemiological dissemination in the other neighboring countries, and knew a fast reduction in time in particular from 2003 [23,31].”
BackgroundSelf-citationTsang, R. S. W., Hoang, L., Tyrrell, G., Horsman, G. B., Caeseele, P. G. V., Jamieson, F., Lefebvre, B., Haldane, D. J. M., Gad, R., German, G., et al. (2017) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v43i78a01f · Cited by 1
“L’augmentation progressive des cas d’infection à MenW au cours des dernières années a d’abord été signalée en Afrique subsaharienne (9) et en Amérique du Sud (10,11).”
BackgroundBrouwer, M. C., & van de Beek, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00034-8 · Cited by 1
Nikiema, A. R., Toé, L., Adjami, G., & Traoré, R. O. (2009) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-009-0003-x · Cited by 1
Development of improved diagnostic testing methods for invasive pneumococcal disease
Werno, A. (2013) · Otago University Research Archive (University of Otago) · Cited by 1
Serotypes and Serogroups implicated in Bacterial meningitis across GhanaPreprint
Weyori, E. W., Abdul-Karim, A., Eleeza, J. B., Nkrumah, B., Abubakari, B. B., Abiwu, H. A. K., Kuugbee, E. D., Yidaana, A., Nuertey, B. D., Adatsi, R. K., et al. (2022) · medRxiv · doi:10.1101/2022.06.10.22276133 · Cited by 1
“In the light of these revelations, implementation of the PCR assay for diagnosis and surveillance of bacterial meningitis in Ghana [11]–[13], Niger [14], [15] and Burkina Faso [16], among the most stricken countries, is an important milestone for the meningitis national control programmes.”
BackgroundUpdate on the Detection and Characterization of Bacterial Pathogens by Nucleic Acid Amplification
Loens, K., Goossens, H., & Ieven, M. M. (2011) · Wiley eBooks · doi:10.1128/9781555816834.ch23
Chaibou, Y., Ouedraogo, M. C., Sanou, I., Somlaré, H., Ouattara, K., Kienou, C., Belem, H., Sampo, E., Traoré, S., Ouedraogo, R. T., et al. (2014) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v15i3.2
Self-citationA 2-year-old child with acute bacterial meningitis
Marriage, S. C., & Coates, L. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581656.004
Evolution of Neisseria and Neisseria Infections
Taha, M. (2014) · ASM Press eBooks · doi:10.1128/9781555815639.ch39
Self-citationStudies on bacterial respiratory pathogens causing bacteraemia and meningitis in South Africa
Gottberg, A. M. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Meningococcal and Pneumococcal Meningitis in Northern Ghana
Fakultät, P.-N. (2007)
Diagnostic challenges with acellular bacterial meningitis
Moolla, Y., & Naidoo, L. (2016) · South African Medical Journal · doi:10.7196/samj.2016.v106i10.10670
Brouwer, M. C., & van de Beek, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-5101-2.00028-5
Prise en charge des infections à Streptococcus pneumoniae : ce qui a changé en 15 ans
Georges, H., & Leroy, O. (2017) · Médecine Intensive Réanimation · doi:10.1007/s13546-017-1265-4 · Cited by 1
“Ce test recommandé par la SPILF en cas d’examen direct négatif et d’antibiothérapie préalable a une sensibilité comprise entre 92 et 100 % et une spécificité voisine de 100 % [31].”
Noora, C. L., Letsa, T. S., Kuma, G. K., Asiedu, E., Kye-Duodu, G., Afari, E. A., Afreh, O. K., Opare, J. K. L., Nyarko, K. M., Ameme, D. K., et al. (2018) · Pan African Medical Journal Conference Proceedings · doi:10.11604/pamj.cp.2017.3.120.470
Approches optimisées du diagnostic de la tuberculose
Diafouka, M. P.-A. (2018) · theses.fr (ABES) · doi:10.70675/116d8e70z9ad5z4edczbf24z9831825edf95 · Cited by 1
AL-Marzoqi, A. H., Al-Janabi, D. K. F., Taee, Z. M. A., & Hussein, H. J. (2012)
Steinhoff, M. C., Cherian, T., & Schlaudecker, E. P. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00027-6
Kandel, C. E., & Gold, W. L. (2018) · Wiley eBooks · doi:10.1002/9781119260363.ch5
Medical Student Journal of Australia: Volume Two, Issue 2
(2011) · Medical Student Journal of Australia · doi:10.22459/msja.02.02.2010
Padget, M. (2016) · theses.fr (ABES) · doi:10.70675/23fe496bz3ec0z4de9zbc5dz65c370ff1ea1 · Cited by 1
“influenzae type B bacteremia 12-24 mo 146 (72-270) * S.”
BackgroundInfluential
Metadata
- Authors
- Chatelet, I. P. D., Traore, Y., Gessner, B. D., Antignac, A., Naccro, B., Njanpop-Lafourcade, B.-M., Ouedraogo, M. S., Tiendrebeogo, S. R., Varon, E., & Taha, M. K.
- Affiliations
- Institut Pasteur (FR)
- Ministère De La Santé (BF)
- Hôpital Européen Georges-Pompidou (FR)
- Corresponding author
- Gessner, B. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 40
- Issue
- 1
- Pages
- 17-25
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2165238552
- Cited by
- 158
- References
- 41
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 11 · 2015: 5 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- bacterial meningitis, meningitis surveillance, Neisseria meningitidis serogroup W135, pneumococcal meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, meningococcal epidemics, seasonal patterns, mortality, Burkina Faso
- MeSH terms
- Adolescent, Adult, Aged, Burkina Faso, Child, Child, Preschool, Humans, Infant, Meningitis, Haemophilus, Meningitis, Meningococcal, Meningitis, Pneumococcal, Middle Aged, Neisseria meningitidis, Population Surveillance, Quality Control, Sensitivity and Specificity, Incidence, Polymerase Chain Reaction, Meningitis, Bacterial, Haemophilus influenzae type b
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.